Lifetime risk for breast and ovarian cancer in postmenopausal BRCA carriers: cause for concern?

被引:0
|
作者
Tice, J. A. [1 ]
Crawford, B. [1 ]
Ziegler, J. [1 ]
McLennan, J. [1 ]
Beattie, M. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S96 / S96
页数:1
相关论文
共 50 条
  • [1] Breast & ovarian cancer risk in BRCA mutation carriers: Implications for prevention
    Catane, R
    Halle, D
    Kaufman, B
    Eisenberg, S
    Isaacson, R
    Chemy, N
    Lahad, A
    Hornreich, G
    Beller, U
    LevyLahad, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 37 - 37
  • [2] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [3] Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations
    Haber, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1660 - 1662
  • [4] Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
    Nanez, Andrea
    Stram, Douglas A.
    Powell, C. Bethan
    Garcia, Christine
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [5] Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers
    Gangi, Alexandra
    Cass, Ilana
    Paik, Daniel
    Barmparas, Galinos
    Karlan, Beth
    Dang, Catherine
    Li, Andrew
    Walsh, Christine
    Rimel, Bobbie J.
    Amersi, Farin F.
    [J]. JAMA SURGERY, 2014, 149 (12) : 1306 - 1313
  • [6] Breast cancer after ovarian cancer in BRCA mutation carriers
    Nanez, A.
    Powell, C. B.
    Garcia, C.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 256 - 256
  • [7] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [8] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    [J]. Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [9] Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
    Fong, Abigail
    Cass, Ilana
    John, Catherine
    Gillen, Jessica
    Moore, Kathleen M.
    Gangi, Alexandra
    Walsh, Christine
    Li, Andrew J.
    Rimel, Bobbie J.
    Karlan, Beth Y.
    Amersi, Farin
    [J]. AMERICAN SURGEON, 2020, 86 (10) : 1243 - 1247
  • [10] IMPACT OF PREGNANCY ON THE RISK OF BREAST AND OVARIAN CANCER IN BRCA1 AND BRCA2 MUTATION CARRIERS
    Russo, M.
    Corvetto, E.
    Fais, M.
    Candotti, G.
    Locati, V.
    Proto, A.
    Angioni, S.
    Carcassi, C.
    Mais, V.
    Peiretti, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A391 - A391